For example, LY3113593, a humanised anti-BMP6 monoclonal antibody, whose mechanism of action is to neutralise BMP6, was shown to be effective in the treatment of anaemia in patients with CKD. The gene discussed is BMP6; the disease is chronic kidney disease.